Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia (Q37877743)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2011

edit

Language	Label	Description	Also known as
English	Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia	scientific article published on June 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

main subject

leukemia

1 reference

based on heuristic

inferred from title

author

Maryalice Stetler-Stevenson

series ordinal

3

object named as

Maryalice Stetler-Stevenson

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

Wyndham H. Wilson

series ordinal

5

object named as

Wyndham H Wilson

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

author name string

Robert J Kreitman

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

Evgeny Arons

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

David J P Fitzgerald

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

Ira Pastan

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

publication date

1 June 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

published in

Leukemia & Lymphoma

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

volume

52 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

page(s)

82-86

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

cites work

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Pentostatin: impact on outcome in hairy cell leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Very long-term eradication of minimal residual disease in patients with hairy cell leukemia after a single course of cladribine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Immunotoxin treatment of cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Eradication of minimal residual disease in hairy cell leukemia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.3109%2F10428194.2011.565843

retrieved

21 January 2018

Responses in refractory hairy cell leukemia to a recombinant immunotoxin

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21599609

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21599609

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21599609

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/21599609

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.3109/10428194.2011.565843

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

PubMed publication ID

21599609

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21599609

retrieved

24 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37877743&oldid=2094966217"